DISCOUNT ZERTIFIKAT - NOVONESIS B Stock

Certificat

DE000PC4JUZ6

Real-time Boerse Frankfurt Warrants 03:20:30 2024-05-21 am EDT
46.13 EUR -0.06% Intraday chart for DISCOUNT ZERTIFIKAT - NOVONESIS B
1 month+2.51%
3 months+4.69%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 46.13 -0.06%
24-05-17 46.16 +0.13%
24-05-16 46.1 +0.15%
24-05-15 46.03 +0.17%
24-05-14 45.95 0.00%

Real-time Boerse Frankfurt Warrants

Last update May 21, 2024 at 03:20 am EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying NOVONESIS A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC4JUZ
ISINDE000PC4JUZ6
Date issued 2024-02-02
Maturity 2024-09-20 (123 Days)
Parity 1 : 1
Emission price 43.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 46.16
Lowest since issue 43.17
Spread 0.05
Spread %0.11%

Company Profile

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Sector
-
More about the company

Ratings for Novonesis A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Novonesis A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
435.4 DKK
Average target price
437.4 DKK
Spread / Average Target
+0.47%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW